Fuping Chen - 02 Dec 2025 Form 4 Insider Report for ACM Research, Inc. (ACMR)

Role
Vice President, Sales-China of ACM Research (Shanghai), Inc., a subsidiary of the Issuer
Signature
/s/ Mark McKechnie, Attorney-in-Fact for Fuping Chen
Issuer symbol
ACMR
Transactions as of
02 Dec 2025
Net transactions value
-$3,768,756
Form type
4
Filing time
04 Dec 2025, 16:30:15 UTC
Previous filing
24 Sep 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Chen Fuping Vice President, Sales-China of ACM Research (Shanghai), Inc., a subsidiary of the Issuer C/O ACM RESEARCH, INC., 42307 OSGOOD ROAD, SUITE I, FREMONT /s/ Mark McKechnie, Attorney-in-Fact for Fuping Chen 04 Dec 2025 0001729184

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACMR Class A Common Stock Options Exercise $177,000 +100,000 $1.77 100,000 02 Dec 2025 Direct
transaction ACMR Class A Common Stock Sale $3,320,000 -100,000 -100% $33.20 0 02 Dec 2025 Direct F1, F2
transaction ACMR Class A Common Stock Options Exercise $35,400 +20,000 $1.77 20,000 03 Dec 2025 Direct
transaction ACMR Class A Common Stock Sale $651,085 -19,700 -98% $33.05 300 03 Dec 2025 Direct F1, F3
transaction ACMR Class A Common Stock Sale $10,071 -300 -100% $33.57 0 03 Dec 2025 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACMR Stock Option Options Exercise $0 -100,000 -71% $0.000000 41,165 02 Dec 2025 Class A Common Stock 100,000 $1.77 Direct F5
transaction ACMR Stock Option Options Exercise $0 -20,000 -49% $0.000000 21,165 03 Dec 2025 Class A Common Stock 20,000 $1.77 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 28, 2025.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.75 to $33.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3), and (4) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.51 to $33.48, inclusive.
F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.53 to $33.59, inclusive.
F5 The option is fully vested and exercisable.

Remarks:

Vice President, Sales-China of ACM Research (Shanghai), Inc., a subsidiary of the Issuer